These 3 Medications Cut Kidney Failure Risk by 40% - Doctors Miss This (Part 5/6) скачать в хорошем качестве

These 3 Medications Cut Kidney Failure Risk by 40% - Doctors Miss This (Part 5/6)

➤ Watch this playlist for more evidence-based info:    • The Kidney Protection Protocol: 6-Part Mas...   ➤ Subscribe for evidence-based health updates:    / @seanhashmimd   ➤ Join 5,000+ getting my free newsletter: https://www.selfprinciple.org/newsletter In this video: Dr. Sean Hashmi, MD, MS, FASN—board-certified Nephrologist and Obesity Medicine Specialist—reveals breakthrough medications that can reduce kidney failure risk by up to 40%. You'll discover exactly how to protect your kidneys with cutting-edge treatments without relying solely on lifestyle changes. Thanks for watching! ➤ KEY INSIGHTS YOU'LL DISCOVER: SGLT-2 inhibitors protect kidneys even in patients WITHOUT diabetes—something most doctors don't realize yet Why combining ACE inhibitors with SGLT-2 inhibitors can reduce kidney failure risk by up to 55% The hidden complications like anemia that accelerate kidney damage and increase death risk ➤ WATCH NEXT: Kidney Protection Protocol: 6-Part Masterclass    • The Kidney Protection Protocol: 6-Part Mas...   Have a question about this video? Drop it in the comments—I read every one and try to respond to as many as I can, often creating videos based on your questions! EXPLORE MORE EVIDENCE-BASED CONTENT: Kidney Health Essentials:    • Kidney Health Essentials   Longevity & General Wellness:    • Longevity & General Wellness   Managing Kidney Disease & Treatments:    • Managing Kidney Disease & Treatments   Live Q&As and Community Support:    • Live Q&As & Community Support   CHAPTERS: 00:00 Maria's Story: From Stable to Dialysis 01:45 SGLT-2 Inhibitors: The Game Changer 04:07 ACE Inhibitors & ARBs: Decades of Protection 05:40 GLP-1 Agonists: Beyond Diabetes 07:11 Hidden Complications: Anemia & Bone Disease 11:04 Everyday Dangers: NSAIDs & Contrast Dye 13:00 Essential Safety Protocols 15:23 When to See a Nephrologist 16:00 Your Action Plan & Next Steps SCIENTIFIC REFERENCES: FLOW Trial: Semaglutide reduced kidney outcomes by 24% in patients with diabetes and CKD (New England Journal of Medicine, 2024) CREDENCE Trial: Canagliflozin reduced kidney failure risk by 30% (New England Journal of Medicine, 2019) RENAAL Study: ARBs reduced kidney events by 16% in diabetic nephropathy (New England Journal of Medicine, 2001) CONNECT WITH DR. HASHMI: Website: https://www.selfprinciple.org Instagram:   / seanhashmimd   Facebook:   / seanhashmimd   TikTok:   / seanhashmimd   Help someone you care about: If you know someone who could benefit from this information, please share this video—it might make a real difference in their health journey. MEDICAL DISCLAIMER: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider for medical decisions. Views expressed are Dr. Hashmi's alone and do not represent any employer or institution. Individual results may vary. Viewing does not establish a doctor-patient relationship. #KidneyHealth #EvidenceBasedMedicine #SGLT2Inhibitors #seanhashmimd #ChronicKidneyDisease